BRAF V600E

Clinical trials for BRAF V600E explained in plain language.

Never miss a new study

Get alerted when new BRAF V600E trials appear

Sign up with your email to follow new studies for BRAF V600E, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet finished but already full! 1 Completed 1

New drug cocktail shows promise against tough lung cancer

Disease control Ongoing

This study tests a combination of two targeted drugs, encorafenib and binimetinib, in people with a specific genetic mutation (BRAF V600E) in advanced non-small cell lung cancer. The goal is to see if the drugs can shrink tumors and slow the cancer's growth. About 119 adults with…

Matched conditions: BRAF V600E

Phase: PHASE2 • Sponsor: Intergroupe Francophone de Cancerologie Thoracique • Aim: Disease control

Last updated May 14, 2026 12:06 UTC

BRAF V600E

Get alerted when new BRAF V600E trials appear

New drug cocktail shows promise against tough lung cancer